Growth Metrics

OptimizeRx (OPRX) Cash from Financing Activities (2010 - 2026)

OptimizeRx recorded quarterly Cash from Financing Activities of -$2.7 million in Q1 2026, up 21.46% quarter-over-quarter from -$3.4 million in Q4 2025, and down 361.33% year-over-year from $1.0 million in Q1 2025.

OptimizeRx's Cash from Financing Activities history runs 13 years deep, the most recent figure standing at -$2.7 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 361.33% year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at -$10.9 million (down 124.76% YoY), while the FY2025 annual figure was -$8.8 million, down 79.15% from the prior year.
  • Cash from Financing Activities came in at -$2.7 million for Q1 2026 at OptimizeRx, up from -$3.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $36.2 million in Q4 2023 to a low of -$12.0 million in Q3 2022.
  • A 5-year average of -$420457.5 and a median of -$640000.0 in 2024 frame the typical range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 586.46% in 2023 and fell as far as 3080.6% in 2023.
  • OptimizeRx's Cash from Financing Activities stood at -$7.4 million in 2022, then surged by 586.46% to $36.2 million in 2023, then tumbled by 107.8% to -$2.8 million in 2024, then decreased by 22.1% to -$3.4 million in 2025, then climbed by 21.46% to -$2.7 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$2.7 million, -$3.4 million, and -$258000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -178.05 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn -70.02 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -137.18 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -112.85 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -93.16 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 13.46 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -8.42 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -10.67 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 2.39 Mn
10 OptimizeRx 101.31 Mn 81.14 Mn 15.12 Mn -2.71 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.71 Mn
Mar 31, 2026 -2.71 Mn
Dec 31, 2025 -3.45 Mn
Dec 31, 2025 -3.45 Mn
Sep 30, 2025 -258,000.00
Sep 30, 2025 -258,000.00
Jun 30, 2025 -4.51 Mn
Jun 30, 2025 -4.51 Mn
Mar 31, 2025 -587,000.00
Mar 31, 2025 -587,000.00
Dec 31, 2024 -2.82 Mn
Dec 31, 2024 -2.82 Mn
Sep 30, 2024 -532,000.00
Sep 30, 2024 -532,000.00
Jun 30, 2024 -915,000.00
Jun 30, 2024 -915,000.00
Mar 31, 2024 -640,000.00
Mar 31, 2024 -640,000.00
Dec 31, 2023 36.19 Mn
Dec 31, 2023 36.19 Mn
Sep 30, 2023 -348,000.00
Sep 30, 2023 -348,000.00
Jun 30, 2023 -7.49 Mn
Jun 30, 2023 -7.49 Mn
Mar 31, 2023 -131,000.00
Mar 31, 2023 -131,000.00
Dec 31, 2022 -7.44 Mn
Dec 31, 2022 -7.44 Mn
Sep 30, 2022 -12.02 Mn
Sep 30, 2022 -12.02 Mn
Jun 30, 2022 251,292.00
Jun 30, 2022 251,292.00
Mar 31, 2022 258,128.00
Mar 31, 2022 258,128.00
Dec 31, 2021 1.06 Mn
Dec 31, 2021 1.06 Mn
Sep 30, 2021 1.09 Mn
Sep 30, 2021 1.09 Mn
Jun 30, 2021 1.59 Mn
Jun 30, 2021 1.59 Mn
Mar 31, 2021 70.18 Mn
Mar 31, 2021 70.18 Mn
Dec 31, 2020 1.16 Mn
Dec 31, 2020 1.16 Mn
Sep 30, 2020 -1.95 Mn
Sep 30, 2020 -1.95 Mn
Jun 30, 2020 -1.21 Mn
Jun 30, 2020 -1.21 Mn
Mar 31, 2020 112,152.00
Mar 31, 2020 112,152.00
Dec 31, 2019 113,279.00
Dec 31, 2019 113,279.00
Sep 30, 2019 206,324.00
Sep 30, 2019 206,324.00
Jun 30, 2019 21.52 Mn
Jun 30, 2019 21.52 Mn
Mar 31, 2019 343,785.00
Mar 31, 2019 343,785.00
Dec 31, 2018 65,322.00
Dec 31, 2018 65,322.00
Sep 30, 2018 451,023.00
Sep 30, 2018 451,023.00
Mar 31, 2016 -357,415.00
Mar 31, 2016 -357,415.00
Mar 31, 2014 2.80 Mn
Mar 31, 2014 2.80 Mn
Dec 31, 2011 -57,500.00
Dec 31, 2011 -57,500.00
Sep 30, 2011 500,000.00
Sep 30, 2011 500,000.00
Dec 31, 2010 650,000.00
Dec 31, 2010 650,000.00